The more than 136,000 Cuban men and women who are victims of rheumatoid arthritis, an irreversible chronic disease that erodes cartilage and bone, and which mainly affects women, will benefit in due course from the massive production and application of the biotechnological product Jusvinza (CIGB-814/258 ), immunoregulatory peptide for the treatment of this condition and hyperinflammation.